India to partially ease ban on export of anti-malarial drugs

On a humanitarian ground, India has decided to ease its restrictions on the export of anti-malarial drug hydroxychloroquine and paracetamol, but only partially.

Anti-malarial drug hydroxychloroquine and paracetamol has proven beneficial in fighting the COVID-19 that motivated India’s decision to put a ban on its export on March 25. India is the largest producer of hydroxychloroquine. But on humanitarian ground, India has decided to fulfil existing orders and to meet the needs of neighbouring countries.

The External Affairs Ministry said the two drugs will also be supplied in “appropriate quantities” to all neighbouring countries dependent on India’s capabilities.

Officials have assured that the existing orders from other countries for hydroxychloroquine and paracetamol will be cleared only after meeting all domestic requirements.

Comments are closed, but trackbacks and pingbacks are open.